Research programme: inositol hexaphosphate analogs - Inositec

Drug Profile

Research programme: inositol hexaphosphate analogs - Inositec

Alternative Names: IP6 - Inositec

Latest Information Update: 04 Nov 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Inositec
  • Class Antibacterials; Calcium regulators; Small molecules
  • Mechanism of Action Bacterial toxin inhibitors; Metabolism inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Clostridium-difficile-infections; Vascular calcification

Most Recent Events

  • 18 Jan 2018 Inositec plans first-in-human studies for Vascular calcification in 2019
  • 27 Oct 2016 Preclinical trials in Clostridium difficile infections in Switzerland (PO)
  • 27 Oct 2016 Preclinical trials in Vascular calcification in Switzerland (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top